Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-04

Clinical Trial Update: A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the interaction between BI 1467335 and tyramine on blood pressure in healthy volunteers was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BI 1467335 (BI 1467335)
  • Tyramine (tyramine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: TERMINATED | Results posted: 2021-06-04